| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,948 |
12,370 |
$348K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,167 |
6,808 |
$138K |
| 59410 |
|
130 |
127 |
$125K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,021 |
957 |
$59K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,394 |
1,338 |
$56K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,157 |
1,149 |
$43K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
889 |
877 |
$31K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
759 |
241 |
$31K |
| 99460 |
|
571 |
561 |
$28K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
522 |
510 |
$27K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
536 |
521 |
$15K |
| 87428 |
|
2,258 |
2,222 |
$14K |
| 59515 |
|
12 |
12 |
$12K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
201 |
196 |
$8K |
| 99215 |
Prolong outpt/office vis |
221 |
213 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
610 |
593 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,529 |
4,403 |
$6K |
| 99233 |
Prolong inpt eval add15 m |
152 |
38 |
$5K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,150 |
2,026 |
$3K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
38 |
37 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,277 |
1,223 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
278 |
264 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
31 |
31 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
14 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
2,510 |
2,388 |
$928.72 |
| 3074F |
|
10,194 |
9,262 |
$601.44 |
| 99442 |
|
39 |
38 |
$511.47 |
| 3079F |
|
3,785 |
3,411 |
$448.37 |
| 3075F |
|
1,389 |
1,323 |
$403.89 |
| 92558 |
|
2,751 |
2,721 |
$372.19 |
| 90686 |
|
1,728 |
1,706 |
$342.02 |
| 92250 |
|
43 |
43 |
$287.29 |
| 0072A |
|
15 |
15 |
$254.80 |
| 90474 |
|
213 |
207 |
$170.00 |
| 0071A |
|
14 |
14 |
$164.80 |
| 81025 |
|
331 |
320 |
$152.88 |
| 85018 |
|
1,324 |
1,257 |
$127.00 |
| 99441 |
|
32 |
32 |
$98.52 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
57 |
51 |
$83.46 |
| 90715 |
|
24 |
24 |
$82.78 |
| 81003 |
|
333 |
321 |
$69.07 |
| 83655 |
|
113 |
103 |
$51.18 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
12 |
$50.90 |
| 90681 |
|
240 |
231 |
$40.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
15 |
15 |
$35.71 |
| 96160 |
|
7,730 |
7,149 |
$15.86 |
| 99000 |
|
4,458 |
4,276 |
$3.00 |
| 90670 |
|
696 |
670 |
$0.12 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,307 |
4,034 |
$0.04 |
| 82962 |
|
41 |
39 |
$0.03 |
| 90710 |
|
193 |
181 |
$0.01 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
9,401 |
8,398 |
$0.00 |
| 99173 |
|
3,051 |
2,990 |
$0.00 |
| 3078F |
|
8,247 |
6,880 |
$0.00 |
| 1159F |
|
4,912 |
4,500 |
$0.00 |
| 1160F |
|
3,840 |
3,576 |
$0.00 |
| 2028F |
|
40 |
37 |
$0.00 |
| 3077F |
|
1,318 |
1,167 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,353 |
2,054 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$0.00 |
| 90734 |
|
206 |
200 |
$0.00 |
| 3046F |
|
270 |
256 |
$0.00 |
| 90633 |
|
307 |
289 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
172 |
148 |
$0.00 |
| 1100F |
|
13 |
12 |
$0.00 |
| 84439 |
|
30 |
29 |
$0.00 |
| 80061 |
Lipid panel |
106 |
102 |
$0.00 |
| 1158F |
|
290 |
275 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
132 |
129 |
$0.00 |
| 81002 |
|
43 |
41 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
81 |
79 |
$0.00 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
59 |
59 |
$0.00 |
| 90700 |
|
13 |
12 |
$0.00 |
| G8511 |
Screening for depression documented as positive, follow-up plan not documented, reason not given |
12 |
12 |
$0.00 |
| 1036F |
|
8,541 |
7,656 |
$0.00 |
| 90651 |
|
363 |
356 |
$0.00 |
| 36416 |
|
609 |
571 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
428 |
396 |
$0.00 |
| 1126F |
|
3,343 |
2,921 |
$0.00 |
| 1125F |
|
1,646 |
1,525 |
$0.00 |
| 90647 |
|
468 |
449 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
134 |
127 |
$0.00 |
| 3080F |
|
643 |
575 |
$0.00 |
| 90723 |
|
504 |
488 |
$0.00 |
| 4000F |
|
299 |
268 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
5,371 |
5,088 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$0.00 |
| 1034F |
|
1,651 |
1,405 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
87 |
83 |
$0.00 |
| 90620 |
|
81 |
81 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
197 |
167 |
$0.00 |
| 81001 |
|
14 |
13 |
$0.00 |
| 3008F |
|
112 |
107 |
$0.00 |
| 36410 |
|
378 |
336 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
197 |
189 |
$0.00 |
| 2023F |
|
29 |
29 |
$0.00 |
| 1000F |
|
61 |
61 |
$0.00 |
| 84436 |
|
27 |
26 |
$0.00 |
| 87536 |
|
13 |
13 |
$0.00 |
| 86592 |
|
13 |
13 |
$0.00 |
| 86361 |
|
13 |
13 |
$0.00 |